Amgen Inc. (AMGN) Financials

AMGN Assets vs Liabilities

DateAssetsLiabilities
March 31, 2024 93.0 billion 88.0 billion
Dec. 31, 2023 97.2 billion 90.9 billion
Sept. 30, 2023 90.5 billion 82.9 billion
June 30, 2023 90.3 billion 83.5 billion

AMGN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
March 31, 2024 459.0 million 103.0 million
Dec. 31, 2023 289.0 million 473.0 million
Sept. 30, 2023 2.8 billion -149.0 million
June 30, 2023 3.8 billion 689.0 million

AMGN Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
March 31, 2024 -113.0 million
Dec. 31, 2023 767.0 million
Sept. 30, 2023 1.7 billion
June 30, 2023 1.4 billion

AMGN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
March 31, 2024 9.7 billion - -
Dec. 31, 2023 10.9 billion - -
Sept. 30, 2023 34.7 billion - -
June 30, 2023 34.2 billion 59.4 billion -

AMGN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
March 31, 2024 536.0 million
Dec. 31, 2023 540.0 million
Sept. 30, 2023 538.0 million
June 30, 2023 537.0 million

AMGN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
March 31, 2024 230.0 million 1.3 billion 1.8 billion -
Dec. 31, 2023 249.0 million 1.5 billion 1.6 billion 647.0 million
Sept. 30, 2023 248.0 million 1.1 billion 1.4 billion -
June 30, 2023 271.0 million 1.1 billion 1.3 billion -

AMGN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
March 31, 2024 7.4 billion 3.2 billion
Dec. 31, 2023 8.2 billion 3.1 billion
Sept. 30, 2023 6.9 billion 1.8 billion
June 30, 2023 7.0 billion 1.8 billion

AMGN

List: Contenders

Price: $308.16

52 week price:
215.32
329.72

Dividend Yield: 0.03%

5-year range yield:
0.03%
3.69%

Forward Dividend Yield: 2.92%

Payout Ratio: 128.39%

Payout Ratio Range:
6.90%
133.00%

Dividend Per Share: 9.00 USD

Earnings Per Share: 6.98 USD

P/E Ratio: 43.70

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 1.7 million

Ebitda: 3.6 billion

Market Capitalization: 163.6 billion

Average Dividend Frequency: 4

Years Paying Dividends: 14

DGR3: 9.10%

DGR5: 9.13%

DGR10: 13.83%

Links: